A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia



Status:Archived
Conditions:Lymphoma, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2009
End Date:March 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Given the tolerability and efficacy of ofatumumab in follicular lymphoma and Chronic
Lymphocytic Leukemia, and the need to improve therapy for patients with WM utilizing a
non-myelosuppressive agent this phase II trial of ofatumumab is being initiated in patients
with Waldenstrom's Macroglobulinemia (WM).



We found this trial at
4
sites
Medical University of South Carolina
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Georgetown Univ Med Ctr
4000 Reservoir Road NW, Suite 120
Washington, Washington DC 20007
(202) 687-0100
Georgetown Univ Med Ctr Georgetown University Medical Center is committed to excellence in research, education...
?
mi
from
Washington, DC
Click here to add this to my saved trials
GSK Investigational Site
Anaheim, California 92807
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
West Virginia University Hospitals Inc.
1 Medical Center Drive
Morgantown, West Virginia 26506
304-598-4800
West Virginia University Hospitals Inc. WVU Healthcare is two corporations, University Health Associates and WVU...
?
mi
from
Morgantown, WV
Click here to add this to my saved trials